Delta Financial Advisors LLC Amgen Inc Transaction History

Delta Financial Advisors LLC

$275 Million
Q3 2024

A detailed history of Delta Financial Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Delta Financial Advisors LLC holds 9,460 shares of AMGN stock, worth $2.79 Million. This represents 1.11% of its overall portfolio holdings.

Number of Shares

9,460

Previous 9,443 0.18%

Holding current value

$2.79 Million

Previous $2.95 Million 3.32%

% of portfolio

1.11%

Previous 1.14%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$309.38 - $337.38 $5,259 - $5,735	17 Added 0.18%	9,460 $3.05 Million
Q2 2024 Aug 06, 2024	BUY	$262.75 - $319.31 $3,941 - $4,789	15 Added 0.16%	9,443 $2.95 Million
Q1 2024 May 07, 2024	BUY	$268.87 - $324.56 $39,255 - $47,385	146 Added 1.57%	9,428 $2.68 Million
Q4 2023 Jan 31, 2024	SELL	$255.7 - $288.46 $154,954 - $174,806	-606 Reduced 6.13%	9,282 $2.67 Million
Q3 2023 Nov 03, 2023	BUY	$218.65 - $271.46 $13,337 - $16,559	61 Added 0.62%	9,888 $2.66 Million
Q2 2023 Aug 03, 2023	BUY	$214.27 - $253.37 $94,064 - $111,229	439 Added 4.68%	9,827 $2.18 Million
Q1 2023 May 04, 2023	SELL	$225.79 - $275.2 $60,285 - $73,478	-267 Reduced 2.77%	9,388 $2.27 Million
Q4 2022 Feb 01, 2023	BUY	$229.03 - $291.01 $3,206 - $4,074	14 Added 0.15%	9,655 $2.54 Million
Q3 2022 Oct 27, 2022	BUY	$224.46 - $253.15 $44,443 - $50,123	198 Added 2.1%	9,641 $2.17 Million
Q2 2022 Aug 01, 2022	SELL	$230.71 - $256.74 $8,074 - $8,985	-35 Reduced 0.37%	9,443 $2.3 Million
Q1 2022 May 06, 2022	SELL	$219.27 - $242.57 $9,647 - $10,673	-44 Reduced 0.46%	9,478 $2.29 Million
Q4 2021 Feb 04, 2022	SELL	$198.88 - $227.6 $94,666 - $108,337	-476 Reduced 4.76%	9,522 $2.14 Million
Q3 2021 Oct 26, 2021	BUY	$212.27 - $248.7 $20,802 - $24,372	98 Added 0.99%	9,998 $2.13 Million
Q2 2021 Aug 04, 2021	BUY	$233.58 - $259.14 $150,191 - $166,627	643 Added 6.95%	9,900 $2.41 Million
Q1 2021 Apr 29, 2021	BUY	$221.91 - $258.6 $3,550 - $4,137	16 Added 0.17%	9,257 $2.3 Million
Q4 2020 Jan 28, 2021	SELL	$216.38 - $257.67 $23,585 - $28,086	-109 Reduced 1.17%	9,241 $2.13 Million
Q3 2020 Oct 20, 2020	SELL	$234.65 - $260.95 $107,469 - $119,515	-458 Reduced 4.67%	9,350 $2.38 Million
Q2 2020 Aug 04, 2020	SELL	$197.81 - $242.74 $64,881 - $79,618	-328 Reduced 3.24%	9,808 $2.31 Million
Q1 2020 Apr 27, 2020	SELL	$182.24 - $241.7 $227,253 - $301,399	-1,247 Reduced 10.95%	10,136 $2.06 Million
Q4 2019 Feb 06, 2020	SELL	$189.21 - $243.2 $28,759 - $36,966	-152 Reduced 1.32%	11,383 $2.74 Million
Q3 2019 Oct 30, 2019	BUY	$174.11 - $208.62 $152,172 - $182,333	874 Added 8.2%	11,535 $2.23 Million
Q2 2019 Oct 11, 2019	BUY	$166.7 - $195.41 $1.78 Million - $2.08 Million	10,661 New	10,661 $1.97 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Delta Financial Advisors LLC with notifications on news.

Account

Delta Financial Advisors LLC Amgen Inc Transaction History